/

Batteries & E-Mobility

/

Vaxxinova US

Vaxxinova US

Vaxxinova US

Verified Nov 2026

Batteries & E-Mobility

·

United States flag

Willmar, Minnesota

·

Since 2002

Vaxxinova US, headquartered in Willmar, Minnesota, and founded in 2002, is a privately held animal health company with 200–500 employees serving the livestock industry. The company develops and manufactures veterinary biologics including licensed and autogenous vaccines for dairy, beef, poultry, and swine. In 2025, Vaxxinova won the S&P Global Animal Health Award for best new food animal product.

Vaxxinova US

Verified Nov 2026

AT A GLANCE

Founded

2002

Headquarters

United States flag

Willmar, Minnesota

Employees

200-500

Ownership

Vaxxinova US at a glance

Revenue

$10-50M

Est. band

Employees

200-500

Founded

2002

Headquarters

Willmar, Minnesota

Industries

Automotive

Electric Vehicles

Industrial Equipment

Overview

Vaxxinova US, headquartered in Willmar, Minnesota, and founded in 2002, is a privately held animal health company with 200–500 employees serving the livestock industry. The company develops and manufactures veterinary biologics including licensed and autogenous vaccines for dairy, beef, poultry, and swine. In 2025, Vaxxinova won the S&P Global Animal Health Award for best new food animal product.

At a glance

Attribute

Detail

Founded

2002

Headquarters

Willmar, Minnesota

Employees

200-500

Revenue

$10-50M (estimated)

Primary capability

Batteries & E-Mobility

What Vaxxinova US makes

Vaxxinova US produces autogenous vaccines and proprietary SRP® Technology products designed to inhibit bacterial growth in livestock.

Latest developments

Facilities

Vaxxinova US is headquartered in Willmar, Minnesota. Public sources also reference these locations:

Company details

The company is part of the global EW Group, which operates in over 100 countries and employs approximately 200 people at its Minnesota locations. Vaxxinova US was founded in 2002, has an estimated 200-500 employees, and is headquartered in Willmar, Minnesota.

Frequently asked questions

What does Vaxxinova US make?

Vaxxinova US, headquartered in Willmar, Minnesota, and founded in 2002, is a privately held animal health company with 200–500 employees serving the livestock industry. The company develops and manufactures veterinary biologics including licensed and autogenous vaccines for dairy, beef, poultry, and swine. In 2025, Vaxxinova won the S&P Global Animal Health Award for best new food animal product.

Where is Vaxxinova US headquartered?

Vaxxinova US is headquartered in Willmar, Minnesota (1801 Biotech Ave NE, Willmar, Minnesota, 56201).

When was Vaxxinova US founded?

Vaxxinova US was founded in 2002.

How big is Vaxxinova US?

Vaxxinova US has an estimated 200-500 employees, with revenue in the $10-50M range (estimated).

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Willmar, Minnesota (HQ)Headquarters · United States
Willmar, Minnesota (HQ)1801 Biotech Ave NE, Willmar, Minnesota, 56201, United StatesHeadquarters

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.